HAEMOSTATIC EFFECT OF ETHANOLIC EXTRACT OF Ageratum conyzoides L TO STRAINS OF MICE MALE SWISS WEBSTER INDUCED WITH COMBINATION OF ASPIRIN, CLOPIDOGREL AND ENOXAPARIN
Keywords:Bleeding, Reversing, Hemostatic, Ageratum conyzoides L
Objective: Bleeding complications are a common concern with the use of combination of antiagregations and anticoagulant agents especially on acute coronary syndrome treatment. In selected situations such as life-threatening, reversing may be desired, but no specific antidotum for the newer agents such as enoxaparin, fondaparinux, levirudin, bivalirudin, and argatroban. Ageratum conyzoides L is a medicinal plants that have a hemostatic effect. The objective of the study is to know the hemostatic effect of A. conyzoides L to induction of acetosal, clopidogrel, and enoxaparin.
Methods: A total of 20 mice are divided into five groups that are normal, negative, positive, Test I and II. There were no treatment for normal, induction of drugs combination for negative, induction of drugs combination and tranexamic acid for positive, induction of drugs combination and ethanolic extract of A. conyzoides L (100 mg/Kg BW) for Test I, induction of drugs combination and ethanolic extract of A. conyzoides L (250 mg/Kg BW) for Test II.
Results: The Test Groups I and II showed reversing of clotting time to normal baseline and shown a significant difference (p<0.05) compared with the negative group. In addition, the Test Groups I and II showed significant difference (p<0.05) of bleeding time compared with the negative group and the Test II (250 mg/Kg BW) shown reversing of bleeding time to normal baseline.
Conclusion: The hemostatic effect showed by ethanolic extract of A. conyzoides L to induction of combination acetosal, clopidogrel and enoxaparin are very valuable for reversing agent novel.
Available from: http://www.who.int/gho/ncd/mortality_morbidity/en/.
Boudi. Coronary Artery Atherosclerosis. Available from: http://www.emedicine.medscape.com/article/153647-overview#a1.2016. [Last accessed on 2017 Mar 14].
Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey ML. Pharmacotherapy A Patophysiologic Approach. New York: Mc Graw Hill; 2008.
American Heart Association. Heart Disease and Stroke Statistic. Update. Dallas, TX: American Heart Association; 2007.
Alam S, Naqvi SB, Ahmed M. Drug utilization and economic impact of anticoagulants in unstable angina/non-St. elevation myocardial infarction in Karachi. Int J Pharm Pharm Sci 2015;7(3):183-5.
Peterson ED, Roe MT, Mulgund J, DeLong ER, Lytle BL, Brindis RG, et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA 2006;295:1912 20.
Eagle KA, Montoye CK, Riba AL, DeFranco AC, Parrish R, Skorcz S, et al. Guideline-based standardized care is associated with substantially lower mortality in medicare patients with acute myocardial infarction: The American college of cardiologyâ€™s guidelines applied in practice (GAP) projects in Michigan. J Am Coll Cardiol 2005;46(7):1242-8.
Hu T, Ma H, Li H, Ren J. Efficacy of cilostazol in patients with acute coronary syndrome after percutaneous coronary intervention. Am J Ther 2013;20(2):151-3.
Sukmawan YP. Cilostazol did not induce any adverse reactions in coronary arterial disease (non-st elevation myocardial infarction) with congestive heart failure comorbidity: A case report. Asian J Pharm Clin Res 2017;10(1):1-2.
Oldgren J, Wernroth L, Stenestrand U; RIKS-HIA registry, Sweden. Fibrinolytic therapy and bleeding complications: Risk predictors from RIKS-HIA. Heart 2010;96(18):1451-7.
Makris M, Van Veen JJ, Tait CR, Mumford AD, Laffan M; British Committee for Standards in Haematology. Guideline on the management of bleeding in patients on antithrombotic agents. Br J Haematol 2013;160(1):35-46.
Petersen JL, Mahaffey KW, Hasselblad V, Antman EM, Cohen M, Goodman SG, et al. Efficacy and bleeding complications among
patients randomized to enoxaparin or unfractionatedheparin for antithrombin therapy in non-Stsegment elevation acute coronary syndromes: A systematic overview. JAMA 2004;292(1):89-96.
Warkentin TE, Crowther MA. Reversing anticoagulants both old and new. Can J Anaesth 2002;49:S11-25.
Van Veen JJ, Maclean RM, Hampton KK, Laidlaw S, Kitchen S, Toth P, et al. Protamine reversal of low molecular weight heparin: Clinically effective? Blood Coagul Fibrinolysis 2011;22(7):565-70.
Kamboj A, Saluja AK. Ageratum conyzoides L.: A review on its phytochemical and pharmacological profile. Int J Green Pharm 2008;2(2):59-68.
Bamidele O, Akinnuga AM, Anyakudo MM, Ojo OA, Ojo GB, Olorunfemi JO, et al. Haemostatic effect of methanolic leaf extract of Ageratum conyzoides in albino mice. J Med Plants Res 2010;4(20):2075 9.
A Diallo B, Batomayenab LE, Povic KE, Gadegbekuc K, Aklikokouc E, Creppyd M, et al. Fetal toxicity of hydroalcoholic extract of Ageratum conyzoides L. leaves (Asteraceae) in rats. Int J Pharm Pharm Sci 2015;7(8):264-6.
Farnsworth NR. Biological and phytochemical screening of plants. J Pharm Sci 1966;55(3):225-76.
Depkes RI. Parameter Standar Umum Extract Tumbuhan. Obat, Jakarta: Depkes RI; 2000.
Vogel HG, editor. Drugs Discovery and Evaluation Pharmacological Assays. New York: Springer; 2008.
Ochei J, Kolhatkar A. Medical Laboratory Science. Theory and Practice. New Delhi; Tata Mcgraw-Hill Publishing Company Limited; 2000.
Cole MR. Evaluation of Hemostasis and Coagulation Disorders in Veterinary Laboratory Medicine. Philadelphia: W.B. Saunders; 1987. p. 43-9.
Isnawati A, Alleganti S, Raini M, Nikmah B. Karakterisasi Simplisia dan Ekstrak Daun Strobilanthus Crispus. Vol. XIV. No. 2. Jakarta: Media Litbang Kesehatan; 2004.
Okoli CO, Akah PA, Okoli AS. Potentials of leaves of Aspilia africana (Compositae) in wound care: An experimental evaluation. BMC Complement Altern Med 2007;7:24.
Galati EM, Miceli N, Taviano MF, Sanogo R, Raneri E. Antiinflammatory and antioxidant activity of Ageratum conyzoides. Pharm Bio 2001;39(5):336-9.
Chung KT, Wong TY, Wei CI, Huang YW, Lin Y. Tannins and human health: A review. Crit Rev Food Sci Nutr 1998;38(6):421-64.
Alquwaizani M, Buckley L, Adams C, Fanikos J. Anticoagulants: A review of the pharmacology, dosing, and complications. Curr Emerg Hosp Med Rep 2013;1(2):83-97.
Savi P, Nurden P, Nurden AT, Levy-Toledano S, Herbert JM. Clopidogrel: A review of its mechanism of action. Platelets 1998;9(3 4):251-5.
Brian A, Robin C, Michael E, Joseph GB, Pamela J, Wayne K, et al. Koda-Kimble and Youngâ€™s Applied Therapeutics: The Clinical Use of Drugs. 10th ed. USA: Lippincott Williams and Wilkins; 2013.
Wajima T, Isbister GK, Duffull SB. A comprehensive model for the humoral coagulation network in humans. Clin Pharmacol Ther 2009;86(3):290-8.
Dapper DV, Achinike PN, Gwotmut MD. Effects of Aloe vera (gel) on clotting time, prothrombin time and plasma fibrinogen concentration in albino Wistar rats. Port Harcourt Med J 2007;2(1):56-60.
How to Cite
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.